SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Brooks Laboratories - Quaterly Results

14 Nov 2022 Evaluate
The sales slipped to Rs. 158.95 millions for the September 2022 quarter as against Rs. 210.51 millions during the year-ago period.The Net Loss for the quarter ended September 2022 is Rs. -8.19 millions as compared to Net Profit of Rs. 10.58 millions of corresponding quarter ended September 2021Operating profit Margin for the quarter ended September 2022 slipped to -2.04% as compared to 15.32% of corresponding quarter ended September 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 158.95 210.51 -24.49 308.38 366.32 -15.82 769.67 772.47 -0.36
Other Income 0.65 3.44 -81.10 1.11 12.67 -91.24 9.48 9.88 -4.05
PBIDT -2.04 15.32 -113.32 -41.94 34.94 -220.03 28.23 17.53 61.04
Interest 1.85 1.24 49.19 3.42 3.05 12.13 6.70 30.94 -78.35
PBDT -3.89 14.08 -127.63 -45.36 31.89 -242.24 21.53 -13.41 -260.55
Depreciation 4.30 3.50 22.86 8.53 7.07 20.65 14.86 70.93 -79.05
PBT -8.19 10.58 -177.41 -53.89 24.82 -317.12 6.67 -84.34 -107.91
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 71.52 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -8.19 10.58 -177.41 -53.89 24.82 -317.12 6.67 -155.86 -104.28
Equity 247.03 247.03 0.00 247.03 247.03 0.00 247.03 247.03 0.00
PBIDTM(%) -1.28 7.28 -117.63 -13.60 9.54 -242.59 3.67 2.27 61.63

Brooks Laboratories Share Price

67.30 0.00 (0.00%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.15
Dr. Reddys Lab 1271.55
Cipla 1353.85
Zydus Lifesciences 1070.90
Lupin 2351.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: